NUS Synthetic Biology for Clinical and Technological Innovation

NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) was formally established in Jan 2015 as the focal research program for synthetic biology at the National University of Singapore. SynCTI operates as a highly interdisciplinary research core that amalgamates leading Principal Investigators from Yong Loo Lin School of Medicine, the Faculty of Science and the Faculty of Engineering. Through research collaborations with renowned international institutes and private industries, SynCTI strives to create new knowledge and develop foundational technologies in synthetic biology and groom future generations of highly skilled researchers endowed with basic science and translational research capabilities.


“What I cannot create, I cannot understand.”Richard Feynman



To anchor Singapore as one of the leading Synthetic Biology Hubs in the world and to develop novel biological and biologically-based systems with advanced clinical and industrial applications.



To create new knowledge and foundational technologies in synthetic biology, with the overall aim of solving grand challenges in society and developing a world-class research program in synthetic biology.


Contact Form